What is he best known for?
The fields of study he is best known for:
Tatsuhiko Furukawa mainly investigates Molecular biology, Biochemistry, Transfection, Cell culture and Thymidine phosphorylase.
His research integrates issues of In vitro, Doxorubicin, Complementary DNA, Efflux and Sodium butyrate in his study of Molecular biology.
The Transfection study which covers Epidermoid carcinoma that intersects with ATOX1 and ATPase.
His biological study spans a wide range of topics, including P-glycoprotein, Cancer cell, ABCC1 and Kinase, Cell biology.
His research investigates the link between P-glycoprotein and topics such as Tyrosine-kinase inhibitor that cross with problems in Cancer research.
His Thymidine phosphorylase research is multidisciplinary, relying on both Tumor progression, Angiogenesis, Antibody and Thymidine.
His most cited work include:
- Angiogenic activity of enzymes (312 citations)
- Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance (277 citations)
- Angiogenic factor [12] (272 citations)
What are the main themes of his work throughout his whole career to date?
Tatsuhiko Furukawa mostly deals with Molecular biology, Biochemistry, Cancer research, Thymidine phosphorylase and Cell culture.
Tatsuhiko Furukawa works mostly in the field of Molecular biology, limiting it down to topics relating to Apoptosis and, in certain cases, Cell biology and Downregulation and upregulation, as a part of the same area of interest.
His Biochemistry research is multidisciplinary, incorporating perspectives in P-glycoprotein and Multiple drug resistance.
His Multiple drug resistance research incorporates themes from Cepharanthine, In vitro, Efflux and Doxorubicin.
His studies in Cancer research integrate themes in fields like Cancer cell, Cancer, Cell growth, Leukemia and Drug resistance.
The concepts of his Thymidine phosphorylase study are interwoven with issues in Tumor progression, Angiogenesis and Thymidine.
He most often published in these fields:
- Molecular biology (36.25%)
- Biochemistry (31.25%)
- Cancer research (27.50%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (27.50%)
- Cancer (6.87%)
- Lung cancer (3.12%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Cancer, Lung cancer, Cell cycle and Thymidine phosphorylase.
The study incorporates disciplines such as Lymphovascular invasion, Metastasis, Gene knockdown, Cell growth and Downregulation and upregulation in addition to Cancer research.
His studies deal with areas such as Efflux, Drug resistance and Genotype as well as Cancer.
His studies in Cell cycle integrate themes in fields like Molecular biology and Cell biology.
He has researched Thymidine phosphorylase in several fields, including MTT assay, Gene silencing and DNA, Thymidine.
His Serine study necessitates a more in-depth grasp of Biochemistry.
Between 2016 and 2021, his most popular works were:
- MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2 (19 citations)
- Thymidine Catabolism as a Metabolic Strategy for Cancer Survival (17 citations)
- mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency. (12 citations)
In his most recent research, the most cited papers focused on:
Tatsuhiko Furukawa mainly focuses on Cancer, Cancer research, Citrin, Citrulline and Cancer cell.
Tatsuhiko Furukawa has included themes like Cellular pathology and Pathology in his Cancer study.
The study incorporates disciplines such as Lymphovascular invasion and Metastasis in addition to Cancer research.
His Cancer cell research incorporates themes from Combination chemotherapy, Multiple drug resistance, Angiogenesis and Doxorubicin.
His Glycolysis course of study focuses on In vivo and Biochemistry.
His Pharmacology study combines topics in areas such as Efflux and Drug resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
